Agilent Technologies Announces New Leadership in Biological Systems Division
News Feb 17, 2010
Agilent Technologies Inc. has announced the appointments of Robert Schueren as vice president and general manager, Genomics; and John Fjeldsted, Ph.D., as general manager, Liquid Chromatography/Mass Spectrometry.
“The life sciences and biological systems business continues to be a key growth driver for Agilent, and the addition of Robert and John strengthens our current leadership team and positions us well for future success,” said Gustavo Salem, vice president and general manager of Agilent’s Biological Systems Division.
Schueren will be responsible for all genomics operations, including microarrays, QPCR and life science reagents. Most recently, he was global head of companion diagnostics, clinical biomarker, and sample operations at Genentech/Roche.
Fjeldsted will be responsible for managing the LC/MS business and driving market share in high-end LC/MS. He has been with Agilent for more than 25 years and played a key role in the tremendous growth of Agilent’s LC/MS unit.
Additionally, George Stafford has joined Agilent as LC/MS hardware R&D manager. Most recently, Stafford held the position of R&D program manager, responsible for Thermo Fisher Scientific’s LC/MS research programs and university collaborations.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
The BuzzBuster: Could Gene Silencing Help Silence the Housefly?News
Gene silencing dsRNA technology can reduce housefly fertility, showing promise as a pest-control method.READ MORE
Researchers Zoom in on DNA Code Being Read in CellsNews
Scientists have unveiled incredible images of how the DNA code is read and interpreted – revealing new detail about one of the fundamental processes of life. The mechanism for reading DNA and decoding it to build proteins for their needs is common to all animals and plants, and is often hijacked by cancer. The discovery of exactly how the molecular mechanism works, could open up new approaches to cancer treatment.READ MORE